Mindfulness App Training for Heart Disease
(MATCH Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual care, as the study compares mindfulness training to regular routines.
What data supports the effectiveness of the treatment Mindfulness App Training for Heart Disease?
Is mindfulness training safe for humans?
How does the Mindfulness App Training for Heart Disease treatment differ from other treatments?
This treatment is unique because it uses mindfulness training, which can help reduce stress and improve emotional regulation, potentially leading to better exercise capacity and mental health in heart disease patients. Unlike traditional treatments that focus on medication, this approach emphasizes self-care and stress management through mindfulness practices.12345
What is the purpose of this trial?
This study will investigate the feasibility and effects of a smartphone-based mindfulness training program vs. usual care in a sample of stressed midlife and older adults at risk for cardiovascular disease. 105 participants will be randomly assigned to complete a four-week mindfulness training intervention, which involves 28 audio-guided lessons and practice prompts delivered 3x daily, or to continue with their regular routines. Data will be collected at baseline, post-intervention, and three-month follow-up. The study will involve seven laboratory visits, which will include assessments and training on daily life monitoring and intervention procedures. Data assessing subjective and physiological stress reactivity in daily life will be collected for 3 days at pre-intervention, post-intervention, and 3-month follow-up. Passive sensor data will be continuously collected from participants' smartphones and wearable devices to develop models that predict daily life stress. Data will be used to evaluate feasibility of the intervention and assessments in a sample at risk for cardiovascular disease and to test effects of mindfulness training on subjective and physiological stress reactivity.
Research Team
Thomas W Kamarck, PhD
Principal Investigator
University of Pittsburgh
Emily K Lindsay, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
Adults aged 45+ in the Pittsburgh area with hypertension and moderate-to-high cardiovascular risk are eligible. They must have a compatible smartphone, speak English well, and be available for study visits. Excluded are those with severe heart conditions, night shift workers, heavy drinkers or drug users, pregnant women, individuals with certain mental health issues or who practice mind-body exercises regularly.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a smartphone-based mindfulness training program or continue their regular routines for 4 weeks
Post-Intervention Monitoring
Participants complete a second week of daily life monitoring, including assessments of stress reactivity and cardiovascular responses
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a third week of monitoring three months later
Treatment Details
Interventions
- Enhanced Usual Care
- Mindfulness Training
Enhanced Usual Care is already approved in United States, European Union, China for the following indications:
- Hepatic encephalopathy
- Constipation
- Hepatic encephalopathy
- Constipation
- Hepatic encephalopathy
- Constipation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator